AU2017311405B2 - Ischemia/Reperfusion injury - Google Patents

Ischemia/Reperfusion injury Download PDF

Info

Publication number
AU2017311405B2
AU2017311405B2 AU2017311405A AU2017311405A AU2017311405B2 AU 2017311405 B2 AU2017311405 B2 AU 2017311405B2 AU 2017311405 A AU2017311405 A AU 2017311405A AU 2017311405 A AU2017311405 A AU 2017311405A AU 2017311405 B2 AU2017311405 B2 AU 2017311405B2
Authority
AU
Australia
Prior art keywords
ischemia
reperfusion injury
reperfusion
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017311405A
Other languages
English (en)
Other versions
AU2017311405A1 (en
Inventor
Joseph Y. CHEUNG
Arthur M. Feldman
Kamel Khalili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple Univ School of Medicine
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Publication of AU2017311405A1 publication Critical patent/AU2017311405A1/en
Application granted granted Critical
Publication of AU2017311405B2 publication Critical patent/AU2017311405B2/en
Priority to AU2023237152A priority Critical patent/AU2023237152B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2017311405A 2016-08-11 2017-08-10 Ischemia/Reperfusion injury Active AU2017311405B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023237152A AU2023237152B2 (en) 2016-08-11 2023-09-28 Ischemia/Reperfusion injury

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662373410P 2016-08-11 2016-08-11
US62/373,410 2016-08-11
PCT/US2017/046237 WO2018031738A2 (en) 2016-08-11 2017-08-10 Ischemia/reperfusion injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023237152A Division AU2023237152B2 (en) 2016-08-11 2023-09-28 Ischemia/Reperfusion injury

Publications (2)

Publication Number Publication Date
AU2017311405A1 AU2017311405A1 (en) 2019-02-28
AU2017311405B2 true AU2017311405B2 (en) 2023-07-13

Family

ID=61162527

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2017311405A Active AU2017311405B2 (en) 2016-08-11 2017-08-10 Ischemia/Reperfusion injury
AU2023237152A Active AU2023237152B2 (en) 2016-08-11 2023-09-28 Ischemia/Reperfusion injury

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023237152A Active AU2023237152B2 (en) 2016-08-11 2023-09-28 Ischemia/Reperfusion injury

Country Status (10)

Country Link
US (2) US20190183971A1 (https=)
EP (1) EP3496726A4 (https=)
JP (1) JP7164885B2 (https=)
KR (2) KR20240130829A (https=)
CN (1) CN109937045A (https=)
AU (2) AU2017311405B2 (https=)
CA (1) CA3033633A1 (https=)
IL (2) IL264760B2 (https=)
MX (1) MX2019001729A (https=)
WO (1) WO2018031738A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110438159B (zh) * 2019-07-03 2023-02-28 广州中医药大学(广州中医药研究院) 一种引发肌原纤维肌病的基因突变小鼠模型的构建方法
CN113082048B (zh) * 2021-05-08 2022-06-10 中国人民解放军陆军军医大学第二附属医院 一种Se@BSA纳米药物的制备方法及其在急性肾损伤中的应用
CN113502260A (zh) * 2021-07-16 2021-10-15 新疆医科大学第一附属医院 一种小鼠乳鼠原代心肌细胞分离与培养方法及其应用
JP2025514489A (ja) * 2022-05-03 2025-05-02 テンプル ユニバーシティー オブ ザ コモンウェルス システム オブ ハイアー エデュケーション 脳におけるｂａｇ３およびタンパク質品質管理

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175958A1 (en) * 2002-03-15 2003-09-18 Reed John C. Methods for using bag expression as a cell differentiation agent and marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
CN102170911B (zh) 2008-08-01 2014-07-02 克里夫兰生物实验室公司 用于治疗再灌注损伤的方法
KR101436684B1 (ko) * 2012-03-09 2014-09-01 가톨릭대학교 산학협력단 저산소성 허혈 예방 또는 치료용 조성물
WO2015117010A2 (en) * 2014-01-31 2015-08-06 Temple University Of The Commonwealth System Of Higher Education Bag3 as a target for therapy of heart failure

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175958A1 (en) * 2002-03-15 2003-09-18 Reed John C. Methods for using bag expression as a cell differentiation agent and marker

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YAYU MA, YA GAI, JINGPENG YAN, JIAN LI, YANGYANG ZHANG: "Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy", MEDICAL SCIENCE MONITOR, vol. 22, 1 January 2016 (2016-01-01), pages 977 - 983, XP055677552, DOI: 10.12659/MSM.897379 *

Also Published As

Publication number Publication date
JP2019527736A (ja) 2019-10-03
IL264760B1 (en) 2023-03-01
AU2023237152B2 (en) 2026-01-22
EP3496726A4 (en) 2020-05-06
KR20240130829A (ko) 2024-08-29
KR20190042609A (ko) 2019-04-24
US20190183971A1 (en) 2019-06-20
CN109937045A (zh) 2019-06-25
IL300767A (en) 2023-04-01
CA3033633A1 (en) 2018-02-15
MX2019001729A (es) 2019-11-12
US20230390357A1 (en) 2023-12-07
AU2023237152A1 (en) 2023-10-19
JP7164885B2 (ja) 2022-11-02
IL264760B2 (en) 2023-07-01
IL264760A (https=) 2019-03-31
WO2018031738A2 (en) 2018-02-15
EP3496726A2 (en) 2019-06-19
IL300767B1 (en) 2026-03-01
AU2017311405A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
IL300767B1 (en) Regional ischemia/reperfusion injury
EP3177334A4 (en) Accessory part
HK40010295A (en) Ischemia/reperfusion injury
AU2016901565A0 (en) Pet accessory
EM34559060001S (nl) Logo's
EM34559060002S (lv) Logotipi
EM34403040002S (nl) Logo's
EM34403040001S (et) Logod
EM34305110001S (fi) Logot
EM34180370001S (da) Logoer
EM14519420001S (mt) Logos
EM33245160011S (cs) Loga
EM33245160005S (en) Logos
EM33245160013S (el) Λογότυπα
EM33245160001S (hr) Logotipi
EM33245160010S (da) Logoer
EM33245160009S (fi) Logot
EM33245160008S (it) Loghi
EM33245160007S (es) Logotipos
EM33245160006S (en) Logos
EM33245160014S (es) Logotipos
EM33245160003S (it) Loghi
EM33245160002S (el) Λογότυπα
EM32321230002S (fi) Logot
EM32321230003S (sk) Logá

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)